Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis.
Thita ChiasakulRobert ReddRushad PatellAdeel M KhanEllen P McCarthyDonna NeubergJeffrey I ZwickerPublished in: Journal of thrombosis and haemostasis : JTH (2021)
In this population-based study, warfarin was associated with improved OS compared with LMWH for the treatment of cancer-associated VTE.